Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACKS: Melatonin for Actinic Keratosis
NCT05740969Phase 2Unknown
- Start
- Feb 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Mucomel in actinic keratosis (AK). Status: unknown.
02
Drugs
Mucomel
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT05740969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05740969.